Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data
- PMID: 39036314
- PMCID: PMC11256685
- DOI: 10.1016/j.jncc.2023.01.002
Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data
Abstract
Background: Esophageal cancer poses a significant global burden, while its patterns and trends remain to be clarified. The aim of this study is to provide an update on the incidence and mortality rates of esophageal cancer and their trends in China based on data from the National Cancer Registry.
Methods: We extracted data from the National Central Cancer Registry (NCCR) of China from 2000 to 2016 and performed comprehensive quality control. We calculated age-standardized rates of China (ASR China) and world (ASR world) using the Chinese population in 2000 and the Segi's world standard population, and performed a joinpoint regression analysis to examine the trend in incidence and mortality of esophageal cancer. The annual percent change (APC) and weighted average APC (AAPC) over the entire study period were estimated to measure the changing trend. Subgroup analyses were conducted by sex, region and pathological type.
Results: A total of 487 eligible cancer registries were included in the data analysis and 22 registries with uninterrupted registration data were used for trend analysis. In 2016, there were an estimated of 184,500 incident cases of esophageal cancer and 142,300 deaths in China. The crude incidence, ASR China and ASR world were 25.25/100,000, 11.00/100,000 and 11.13/100,000, respectively. And the crude mortality, ASR China and ASR world were 19.38/100,000, 8.25/100,000 and 8.28/100,000, respectively. Esophageal squamous cell carcinoma (ESCC) was the most common histological type, accounting for 85.79% of all cases, followed by esophageal adenocarcinoma (EAC) (11.00%) and others (3.21%). There was a decreasing trend of ASR world in incidence and mortality during 2000-2016 with the AAPC of -4.6% (95% CI: -5.7%, -3.4%) and -4.6% (95% CI: -5.2%, -3.9%). The pattern and trend of esophageal cancer differ in sex, region and pathological type.
Conclusions: The burden of esophageal cancer in China remains high with sex, regional and subtype differences. The incidence and mortality of esophageal cancer have continued to decline over the past decade, which was due in part to the reductions in risk factor exposure and the implementation of screening.
Keywords: China; Esophageal cancer; Incidence; Mortality; Trends.
© 2023 Chinese National Cancer Center. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no conflict of interests.
Figures



Similar articles
-
[Analysis of incidence and mortality of esophageal cancer in China, 2015].Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Nov 6;53(11):1094-1097. doi: 10.3760/cma.j.issn.0253-9624.2019.11.004. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 31683393 Chinese.
-
[Liver cancer epidemiology in China, 2015].Zhonghua Zhong Liu Za Zhi. 2019 Oct 23;41(10):721-727. doi: 10.3760/cma.j.issn.0253-3766.2019.10.001. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31648492 Chinese.
-
[Changing trend of incidence and mortality of esophageal cancer during 2010-2016 in Henan Province, China].Zhonghua Zhong Liu Za Zhi. 2022 Jan 23;44(1):86-92. doi: 10.3760/cma.j.cn112152-20200605-00526. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35073653 Chinese.
-
International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.Esophagus. 2022 Oct;19(4):560-568. doi: 10.1007/s10388-022-00927-4. Epub 2022 Jun 11. Esophagus. 2022. PMID: 35689719 Review.
-
Changes in Esophageal Cancer Survival: A Global Review of Survival Analysis from Cancer Registration Data over the Past Three Decades.Biomed Environ Sci. 2025 May 20;38(5):571-584. doi: 10.3967/bes2025.018. Biomed Environ Sci. 2025. PMID: 40506379 Review.
Cited by
-
Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis.Front Immunol. 2024 Sep 20;15:1453482. doi: 10.3389/fimmu.2024.1453482. eCollection 2024. Front Immunol. 2024. PMID: 39372418 Free PMC article.
-
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.Ther Adv Med Oncol. 2024 Nov 19;16:17588359241297092. doi: 10.1177/17588359241297092. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39563718 Free PMC article.
-
Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China.Cancers (Basel). 2023 Nov 27;15(23):5604. doi: 10.3390/cancers15235604. Cancers (Basel). 2023. PMID: 38067307 Free PMC article. Review.
-
Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer.PeerJ. 2024 Jan 31;12:e16802. doi: 10.7717/peerj.16802. eCollection 2024. PeerJ. 2024. PMID: 38313016 Free PMC article. Review.
-
Exosomes in esophageal cancer: a promising frontier for liquid biopsy in diagnosis and therapeutic monitoring.Front Pharmacol. 2024 Dec 17;15:1459938. doi: 10.3389/fphar.2024.1459938. eCollection 2024. Front Pharmacol. 2024. PMID: 39741631 Free PMC article. Review.
References
-
- Sung H., Ferlay J., Siegel R.L., et al. global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- Lagergren J., Smyth E., Cunningham D., et al. Oesophageal cancer. Lancet. 2017;390:2383–2396. - PubMed
-
- Morgan E., Soerjomataram I., Rumgay H., et al. the global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649–658. e2. - PubMed
-
- Zheng R., Zhang S., Zeng H., et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2:1–9.
LinkOut - more resources
Full Text Sources
Miscellaneous